Correction to: Tracking Japan's development assistance for health, 2012-2016.
作者信息
Nomura Shuhei, Sakamoto Haruka, Sugai Maaya Kita, Nakamura Haruyo, Maruyama-Sakurai Keiko, Lee Sangnim, Ishizuka Aya, Shibuya Kenji
机构信息
Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
出版信息
Global Health. 2021 Jan 4;17(1):2. doi: 10.1186/s12992-020-00640-w.
Abstract
摘要
相似文献
1
Correction to: Tracking Japan's development assistance for health, 2012-2016.对《追踪日本2012 - 2016年卫生发展援助》的勘误
Global Health. 2021 Jan 4;17(1):2. doi: 10.1186/s12992-020-00640-w.
2
Tracking Japan's development assistance for health, 2012-2016.追踪日本 2012-2016 年卫生发展援助情况。
Global Health. 2020 Apr 15;16(1):32. doi: 10.1186/s12992-020-00559-2.
3
Japan's contribution to clinical research in gastroenterology and hepatology.日本对胃肠病学和肝病学临床研究的贡献。
J Gastroenterol. 2003;38(8):816-9. doi: 10.1007/s00535-003-1153-4.
4
An evaluation of fertility- and migration-based policy responses to Japan's ageing population.评估生育和移民政策对日本人口老龄化的反应。
PLoS One. 2018 Dec 19;13(12):e0209285. doi: 10.1371/journal.pone.0209285. eCollection 2018.
5
Japan's anti-nuclear weapons policy misses its target, even in the war on terrorism.日本的反核武器政策即使在反恐战争中也未达到其目标。
Med Confl Surviv. 2003 Jul-Sep;19(3):235-48. doi: 10.1080/13623690308409694.
6
Future of Japan's system of good health at low cost with equity: beyond universal coverage.日本实现低成本、公平的全民健康系统的未来：超越全民覆盖。
Lancet. 2011 Oct 1;378(9798):1265-73. doi: 10.1016/S0140-6736(11)61098-2. Epub 2011 Aug 30.
7
Lessons from the Field Count more than Ever: The New Era of Global Health.来自实地的经验教训比以往任何时候都更重要：全球健康的新时代。
Trop Med Health. 2015 Dec;43(4):243-5. doi: 10.2149/tmh.2015-37. Epub 2015 Oct 10.
8
Hospital reimbursement schemes. Japan's point system and the United States' diagnosis-related groups.医院报销方案。日本的积分制和美国的诊断相关分组。
Med Care. 1985 Sep;23(9):1055-66.
9
Reconsidering Japan's underperformance in pharmaceuticals: evidence from Japan's anticancer drug sector.重新审视日本制药行业的表现不佳：来自日本抗癌药物领域的证据。
Enterp Soc. 2010;11(3):560-93. doi: 10.1093/es/khq063.
10
[Japan's official development assistance in medicine and public health].
Nihon Koshu Eisei Zasshi. 1991 Nov;38(11):839-41.
本文引用的文献
1
Tracking Japan's development assistance for health, 2012-2016.追踪日本 2012-2016 年卫生发展援助情况。
Global Health. 2020 Apr 15;16(1):32. doi: 10.1186/s12992-020-00559-2.
Zotero 插件